AUGMEDIX INC (AUGX) Stock Price & Overview
NASDAQ:AUGX • US05105P1075
The current stock price of AUGX is 2.35 USD. Today AUGX is down by 0%. In the past month the price increased by 1.73%. In the past year, price decreased by -53.47%.
AUGX Key Statistics
- Market Cap
- 116.161M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.44
- Dividend Yield
- N/A
AUGX Stock Performance
AUGX Stock Chart
AUGX Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to AUGX. When comparing the yearly performance of all stocks, AUGX is one of the better performing stocks in the market, outperforming 90.44% of all stocks.
AUGX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AUGX. AUGX has a bad profitability rating. Also its financial health evaluation is rather negative.
AUGX Earnings
On August 12, 2024 AUGX reported an EPS of -0.13 and a revenue of 13.66M. The company beat EPS expectations (4.41% surprise) and missed revenue expectations (-1.76% surprise).
AUGX Forecast & Estimates
10 analysts have analysed AUGX and the average price target is 3.6 USD. This implies a price increase of 53% is expected in the next year compared to the current price of 2.35.
For the next year, analysts expect an EPS growth of -20.13% and a revenue growth 18.97% for AUGX
AUGX Groups
Sector & Classification
AUGX Financial Highlights
Over the last trailing twelve months AUGX reported a non-GAAP Earnings per Share(EPS) of -0.44. The EPS increased by 15.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -44.44% | ||
| ROE | -227.72% | ||
| Debt/Equity | 1.48 |
AUGX Ownership
AUGX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 22.33 | 32.228B | ||
| WAY | WAYSTAR HOLDING CORP | 15.57 | 5.085B | ||
| DOCS | DOXIMITY INC-CLASS A | 14.47 | 4.815B | ||
| HTFL | HEARTFLOW INC | N/A | 2.117B | ||
| CERT | CERTARA INC | 14.08 | 1.138B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 227.63 | 1.088B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.087B | ||
| SDGR | SCHRODINGER INC | N/A | 962.005M | ||
| TDOC | TELADOC HEALTH INC | N/A | 913.408M | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 6.21 | 784.485M | ||
| PHR | PHREESIA INC | 18.45 | 728.303M | ||
| HSTM | HEALTHSTREAM INC | 29.08 | 642.69M | ||
| EVH | EVOLENT HEALTH INC - A | 11.67 | 379.576M |
Related stock screener links
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AUGX
Company Profile
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 1,430 full-time employees. The company went IPO on 2021-03-04. The firm uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. The company also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.
Company Info
AUGMEDIX INC
111 Sutter Street, Suite 1300
San Francisco CALIFORNIA US
CEO: Emmanuel Krakaris
Employees: 1430
Phone: 15619892208
AUGMEDIX INC / AUGX FAQ
Can you describe the business of AUGMEDIX INC?
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 1,430 full-time employees. The company went IPO on 2021-03-04. The firm uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. The company also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.
What is the stock price of AUGMEDIX INC today?
The current stock price of AUGX is 2.35 USD.
What is the dividend status of AUGMEDIX INC?
AUGX does not pay a dividend.
What is the ChartMill rating of AUGMEDIX INC stock?
AUGX has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the analyst forecast for AUGX stock?
10 analysts have analysed AUGX and the average price target is 3.6 USD. This implies a price increase of 53% is expected in the next year compared to the current price of 2.35.
Is AUGMEDIX INC (AUGX) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AUGX.